Researchers identified three distinct brain “biotypes” of ADHD, each with its own chemical signature—offering new clues about why treatment can feel like trial and error.

These brain areas are central to attention and information processing, emotional regulation, executive function and decision-making – all markers of ADHD. "Despite these promising results, this study ...

Studies reveal a complex interplay of traits, genes, and brain structure behind the dual diagnosis—raising new questions about how we define and treat both conditions.

May 7, 2008 (Washington, DC) — A large neuroimaging study found that in attention deficit/hyperactivity disorder (ADHD), brain development follows a normal trajectory, but maturation of the prefrontal ...

Brain imaging is giving scientists a clearer picture of why attention-deficit/hyperactivity disorder looks so different from one child to the next. New structural MRI work indicates that ADHD is not a ...

A couple of years ago, Jan Haavik was at a routine meeting of a research group that connects scientists studying attention deficit hyperactivity disorder (ADHD) with people who live with the condition ...

Over 22 million Americans are diagnosed with ADHD -- yet an objective biological marker for distinguishing between its three distinct subtypes has, to date, remained elusive(1) Firefly's AI-powered ...

"There is a large placebo effect with high-tech brain therapies, in particular for patients and families that have an expectation that they can adjust brain differences associated with ADHD. It is ...

ADHD stimulants appear to work less by sharpening focus and more by waking up the brain. Brain scans revealed that these medications activate reward and alertness systems, helping children stay ...